Peerschke E I
Blood. 1982 Jul;60(1):71-7.
The ability of epinephrine to expose platelet fibrinogen receptors independent of released ADP was assessed using aspirin-treated, gel-filtered platelets. Similar to ADP-induced aggregation, platelet aggregation in response to epinephrine was accompanied by fibrinogen binding. Ten micromolar epinephrine induced a maximum number of platelet fibrinogen receptors in the absence of significant 14C-serotonin release. As indicated by Scatchard analysis, receptors exposed by both epinephrine and ADP had similar affinities for fibrinogen, but epinephrine induced approximately 30% fewer receptors than did ADP. This appears to correlate with the lesser degree of primary aggregation observed with this agent. Studies using phentolamine, a specific alpha-adrenergic antagonist, apyrase, or creatine phosphate/creatine kinase indicate that the exposure of platelet fibrinogen receptors by epinephrine was specific for platelet alpha-adrenergic receptor stimulation and was not the result of released ADP.
使用阿司匹林处理过的、经凝胶过滤的血小板评估肾上腺素独立于释放的ADP暴露血小板纤维蛋白原受体的能力。与ADP诱导的聚集相似,肾上腺素诱导的血小板聚集伴随着纤维蛋白原结合。在没有显著的14C - 5 -羟色胺释放的情况下,10微摩尔肾上腺素诱导出最大数量的血小板纤维蛋白原受体。如Scatchard分析所示,肾上腺素和ADP暴露的受体对纤维蛋白原具有相似的亲和力,但肾上腺素诱导的受体比ADP少约30%。这似乎与用该试剂观察到的初级聚集程度较低相关。使用酚妥拉明(一种特异性α - 肾上腺素能拮抗剂)、腺苷三磷酸双磷酸酶或磷酸肌酸/肌酸激酶的研究表明,肾上腺素暴露血小板纤维蛋白原受体是血小板α - 肾上腺素能受体刺激所特有的,而不是释放的ADP的结果。